Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib in Advanced Endometrial Cancer
NCT01111461Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of lenvatinib in endometrial cancer (EC), sponsored by Eisai Co., Ltd.. Started Mar 2010; status: completed.
02
Drugs
lenvatinib
03
Conditions
endometrial cancer (EC)
Beyond the preview
Go deeper on NCT01111461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01111461.